发明名称 2-AMINOPYRIMIDINE AND 2-AMINOPYRIDINE-4-CARBAMATES FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES
摘要 <p>The present invention relates to pyrimidine or pyridine carbamate compounds having the general Formula (1) and pharmaceutically acceptable salts or derivatives thereof. Also included are methods of treatment of various diseases and conditions, including inflammation, inhibition of T cell activation and proliferation, arthritis, organ transplant, ischemic or reperfusion injury, myocardial infarction, stroke, multiple sclerosis, inflammatory bowel disease, Crohn's disease, lupus, hypersensitivity, type 1 diabetes, psoriasis, dermatitis, Hashimoto's thyroiditis, Sjogren's syndrome, autoimmune hyperthyroidism, Addison's disease, autoimmune diseases, glomerulonephritis, allergic diseases, asthma, hayfever, eczema, cancer, colon carcinoma, thymoma, just to name a few, in a mammal, the methods comprising administering a therapeutically-effective amount a compound of Formula I, or a salt or derivative form thereof, as described above.</p>
申请公布号 WO2005009978(A1) 申请公布日期 2005.02.03
申请号 WO2004US23233 申请日期 2004.07.15
申请人 AMGEN INC.;BUCHANAN, JOHN, L.;ELBAUM, DANIEL;MARTIN, MATTHEW, W.;MCGOWAN, DAVID, C.;NOVAK, PERRY, M.;NUNES, JOSEPH, J. 发明人 BUCHANAN, JOHN, L.;ELBAUM, DANIEL;MARTIN, MATTHEW, W.;MCGOWAN, DAVID, C.;NOVAK, PERRY, M.;NUNES, JOSEPH, J.
分类号 A61P37/00;C07D213/75;C07D239/48;C07D401/12;C07D403/12;C07D405/12;C07D413/12;C07D417/12;C07D471/04;(IPC1-7):C07D239/48;A61K31/505 主分类号 A61P37/00
代理机构 代理人
主权项
地址